CHRISTY MASTERMAN: Open Payments
NPI 1841396413 · KENNEWICK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,312 in 101 payments from 13 companies in 2025. Trend: 2023 $1,191 · 2024 $1,393 · 2025 $1,312
Food & beverage: $1,312
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 64 | $716 |
| ABBVIE INC. | 12 | $153 |
| LEO Pharma Inc. | 4 | $77 |
| Arcutis Biotherapeutics, Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $53 |
| UCB, Inc. | 3 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $48 |
| Incyte Corporation | 2 | $41 |
| GENZYME CORPORATION | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
Products named: TREMFYA, SKYRIZI, Zoryve, TALTZ, DUPIXENT, Bimzelx, RINVOQ, OPZELURA.
Industry payments across WA — which companies pay providers there.
